Healthcare - Biotechnology - NASDAQ - US
$ 9.16
-7.66 %
$ 1.43 B
Market Cap
-8.4
P/E
Price Target
Average
91.05%
Revenue Forecast
Estimate
68.30%
EBIT
Estimate
--54.46%
Net Income
Estimate
21.79%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Ocular Therapeutix, Inc.
Wall Street analysts predict an average 1-year price target for OCUL of $17.5 , with forecasts ranging from a low of $14 to a high of $24 .
OCUL Lowest Price Target
Wall Street Target
14 USD
52.84%
OCUL Average Price Target
Wall Street Target
17.5 USD
91.05%
OCUL Highest Price Target
Wall Street Target
24 USD
162.01%
REVENUE FORECAST
Revenue Forecast Chart OCUL
EBIT FORECAST
EBIT Forecast Chart OCUL
NET INCOME FORECAST
Net Income Chart OCUL